Presenilin mutations and calcium signaling defects in the nervous and immune systems.
暂无分享,去创建一个
M. Mattson | Sic L. Chan | S. Camandola | M P Mattson | S Camandola | S L Chan | S. Chan
[1] K. Mikoshiba,et al. The calmodulin-binding domain in the mouse type 1 inositol 1,4,5-trisphosphate receptor. , 1995, The Biochemical journal.
[2] Miles W. Miller,et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice , 1999, Nature Medicine.
[3] D. Selkoe,et al. Calcium ionophore increases amyloid beta peptide production by cultured cells. , 1994, Biochemistry.
[4] F. Urano,et al. Upregulation of BiP and CHOP by the unfolded-protein response is independent of presenilin expression , 2000, Nature Cell Biology.
[5] H. Anisman,et al. Alterations in immune functions during normal aging and Alzheimer's disease , 1999, Psychiatry Research.
[6] J. Rossant,et al. Notch1 is required for the coordinate segmentation of somites. , 1995, Development.
[7] M. Mattson,et al. The Endoplasmic Reticulum Stress-Responsive Protein GRP78 Protects Neurons Against Excitotoxicity and Apoptosis: Suppression of Oxidative Stress and Stabilization of Calcium Homeostasis , 1999, Experimental Neurology.
[8] I. Greenwald,et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[9] C. Masters,et al. Proteolytic Processing of Alzheimer's Disease βA4 Amyloid Precursor Protein in Human Platelets (*) , 1995, The Journal of Biological Chemistry.
[10] D. Selkoe,et al. In search of γ-secretase: Presenilin at the cutting edge , 2000 .
[11] D. Ibarreta,et al. Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. , 1997, Alzheimer disease and associated disorders.
[12] A. Guse. Ca2+ signaling in T-lymphocytes. , 1998, Critical reviews in immunology.
[13] S. Snyder,et al. Type 3 inositol 1,4,5‐trisphosphate receptor modulates cell death , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] T. Holzman,et al. Cleavage of fluorogenic substrates for APP-processing proteases by human brain extracts. Ca(2+)-substrate interaction is responsible for Ca2+ stimulation of the neural protease activity. , 1994, Molecular and chemical neuropathology.
[15] M. Mattson,et al. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor , 1996 .
[16] S. Govoni,et al. Increased Natural Killer Cell Cytotoxicity in Alzheimer’s Disease May Involve Protein Kinase C Dysregulation , 1998, Neurobiology of Aging.
[17] P. Mecocci,et al. Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.
[18] Mark P. Mattson,et al. Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.
[19] M. Mattson,et al. Presenilin-1 Mutations Increase Levels of Ryanodine Receptors and Calcium Release in PC12 Cells and Cortical Neurons* , 2000, The Journal of Biological Chemistry.
[20] Y. Itoyama,et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response , 1999, Nature Cell Biology.
[21] S. Snyder,et al. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux , 1995, Cell.
[22] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[23] G. Schellenberg,et al. Presenilin‐1 mutation alters NGF‐induced neurite outgrowth, calcium homeostasis, and transcription factor (AP‐1) activation in PC12 cells , 1998, Journal of neuroscience research.
[24] C. Cotman,et al. Alzheimer's Presenilin-1 Mutation Potentiates Inositol 1,4,5-Trisphosphate-Mediated Calcium Signaling in Xenopus , 1999 .
[25] V. Pickel,et al. Ultrastructural localization of sorcin, a 22 kDa calcium binding protein, in the rat caudate‐putamen nucleus: Association with ryanodine receptors and intracellular calcium release , 1997, The Journal of comparative neurology.
[26] H. Lodish,et al. Perturbation of cellular calcium blocks exit of secretory proteins from the rough endoplasmic reticulum. , 1990, The Journal of biological chemistry.
[27] C. Culmsee,et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide , 2001 .
[28] M. Mattson. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons , 1990, Neuron.
[29] K. Oka,et al. Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[31] G. Struhl,et al. Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] Peter Walter,et al. A Role for Presenilin-1 in Nuclear Accumulation of Ire1 Fragments and Induction of the Mammalian Unfolded Protein Response , 1999, Cell.
[33] F. Checler,et al. α‐Secretase‐Derived Product of β‐Amyloid Precursor Protein Is Decreased by Presenilin 1 Mutations Linked to Familial Alzheimer's Disease , 1997 .
[34] Iva Greenwald,et al. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene , 1995, Nature.
[35] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[36] L. Bourguignon,et al. Identification of the Ankyrin-binding Domain of the Mouse T-lymphoma Cell Inositol 1,4,5-Trisphosphate (IP3) Receptor and Its Role in the Regulation of IP3-mediated Internal Ca2+ Release (*) , 1995, The Journal of Biological Chemistry.
[37] A. Marks,et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein , 1994, Cell.
[38] M. Kennedy,et al. Hippocampal Neurons Predisposed to Neurofibrillary Tangle Formation Are Enriched in Type II Calcium/Calmodulin-Dependent Protein Kinase , 1990, Journal of neuropathology and experimental neurology.
[39] P. Bongioanni,et al. T-lymphocyte interleukin 6 receptor binding in patients with dementia of Alzheimer type. , 1998, Archives of neurology.
[40] Hiroshi Takahashi,et al. Impaired proteolytic processing of Presenilin-1 in chromosome 14-linked familial Alzheimer's disease patient lymphocytes , 1999, Neuroscience Letters.
[41] M. Mattson,et al. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: reduced oxidative stress and preserved mitochondrial function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] M. Mattson,et al. Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal Ischemia In Vivo and to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis , 2000, The Journal of Neuroscience.
[43] M. Mattson,et al. Activation of K+ channels and suppression of neuronal activity by secreted β-amyloid-precursor protein , 1996, Nature.
[44] R J Mark,et al. Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation , 1997, The Journal of Neuroscience.
[45] M. Castagna,et al. T-cell tumour necrosis factor-α receptor binding in demented patients , 1997, Journal of Neurology.
[46] M. Mattson,et al. Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis* , 1998, The Journal of Biological Chemistry.
[47] S. Estus,et al. Aggregated Amyloid-β Protein Induces Cortical Neuronal Apoptosis and Concomitant “Apoptotic” Pattern of Gene Induction , 1997, The Journal of Neuroscience.
[48] J. Fastbom,et al. Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and β-amyloid pathologies , 1999, Neuroscience.
[49] G. Johnson,et al. Transglutaminase Cross‐Linking of the τ Protein , 1995 .
[50] M. Berridge,et al. The versatility and universality of calcium signalling , 2000, Nature Reviews Molecular Cell Biology.
[51] T. Sunderland,et al. Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation , 1996, Science.
[52] B. Winblad,et al. Calcium ionophore A23187 specifically decreases the secretion of β‐secretase cleaved amyloid precursor protein during apoptosis in primary rat cortical cultures , 2001, Journal of neuroscience research.
[53] J. Buxbaum,et al. Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment , 1998, Nature Medicine.
[54] M. Mattson,et al. Alzheimer’s Presenilin Mutation Sensitizes Neural Cells to Apoptosis Induced by Trophic Factor Withdrawal and Amyloid β-Peptide: Involvement of Calcium and Oxyradicals , 1997, The Journal of Neuroscience.
[55] E. Urcelay,et al. Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients , 1998, Annals of neurology.
[56] M. Frosch,et al. Presenilin-Mediated Modulation of Capacitative Calcium Entry , 2000, Neuron.
[57] S. Janicki,et al. A Myristoylated Calcium-binding Protein that Preferentially Interacts with the Alzheimer's Disease Presenilin 2 Protein , 1999, The Journal of cell biology.
[58] S. Tonegawa,et al. Skeletal and CNS Defects in Presenilin-1-Deficient Mice , 1997, Cell.
[59] U. Lendahl,et al. Complementary and combinatorial patterns of Notch gene family expression during early mouse development , 1995, Mechanisms of Development.
[60] M. Mattson,et al. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease , 1998, Nature Medicine.
[61] G. Collingridge,et al. Ca2+ and synaptic plasticity. , 1998, Cell calcium.
[62] M. Hennerici,et al. Free Intracellular Calcium in Peripheral Cells in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[63] T B Shea,et al. Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.
[64] J. Aldenhoff,et al. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer’s dementia , 1999, Biological Psychiatry.
[65] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[66] T. Iwatsubo,et al. Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain. , 2000, International journal of molecular medicine.
[67] B. Hyman,et al. Notch1 inhibits neurite outgrowth in postmitotic primary neurons , 1999, Neuroscience.
[68] E. Villacres,et al. Intracellular calcium response is reduced in CD4+ lymphocytes in Alzheimer's disease and in older persons with down's syndrome , 1993, Neurobiology of Aging.
[69] M. Mattson,et al. 4‐hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes , 1998, Glia.
[70] Kenji Matsuno,et al. Notch signaling. , 1995, Science.
[71] M. Mattson,et al. Capacitative Calcium Entry Deficits and Elevated Luminal Calcium Content in Mutant Presenilin-1 Knockin Mice , 2000, The Journal of cell biology.
[72] M. Mattson,et al. Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[73] M. Handler,et al. Presenilin-1 regulates neuronal differentiation during neurogenesis. , 2000, Development.
[74] M. Mattson,et al. Altered Calcium Homeostasis and Mitochondrial Dysfunction in Cortical Synaptic Compartments of Presenilin‐1 Mutant Mice , 1999, Journal of neurochemistry.
[75] J. Buxbaum,et al. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[76] M. Mattson. Apoptotic and Anti‐Apoptotic Synaptic Signaling Mechanisms , 2000, Brain pathology.
[77] R. Tanzi,et al. Presenilin 2 Interacts with Sorcin, a Modulator of the Ryanodine Receptor* , 2000, The Journal of Biological Chemistry.
[78] M. Mattson,et al. Alzheimer's PS‐1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β‐peptide , 1996, Neuroreport.
[79] P. Vito,et al. Functional cloning of genes involved in T-cell receptor-induced programmed cell death. , 1997, Seminars in Immunology.
[80] C. Pike,et al. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. , 2001, Journal of neurochemistry.
[81] B. Osborne,et al. Notch and the immune system. , 1999, Immunity.
[82] D. Selkoe. In search of X-secretase : Presenilins at the cutting edge , 2000 .
[83] D. Linden,et al. Synaptic Transmission and Hippocampal Long-Term Potentiation in Transgenic Mice Expressing FAD-Linked Presenilin 1 , 1999, Neurobiology of Disease.
[84] K. Blomgren,et al. Increased proteolytic activity in lymphocytes from patients with early onset Alzheimer's disease , 1995, Neurobiology of Aging.
[85] R. Empson,et al. Functional Phenotype in Transgenic Mice Expressing Mutant Human Presenilin-1 , 2000, Neurobiology of Disease.
[86] Ralph A. Nixon,et al. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.
[87] M. Mattson,et al. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation , 1999, Brain Research.
[88] G. Boulianne,et al. Drosophila presenilin Is Required for Neuronal Differentiation and Affects Notch Subcellular Localization and Signaling , 1999, The Journal of Neuroscience.
[89] J. Troncoso,et al. α-Calcium-Calmodulin-Dependent Kinase II is Associated with Paired Helical Filaments of Alzheimer's Disease , 1996 .